Antidote is a third-party application that allows you to search for clinical trials. It is not affiliated with, or endorsed by, the BrightFocus Foundation or our website. Please see our disclaimer related to third-party sites for more information.
Additional Clinical Trial Resources:
National Institutes of Health (NIH)
Provides information on government-sponsored human trials and recruitment, with locations, purpose, eligibility requirements, and phone contacts.
- National Institute on Aging (NIA)
How Clinical Trials Work
Clinical trials are used to determine the safety and effectiveness of the drug on progressively larger numbers of people. Researchers rely on volunteers to bring their research closer to their ultimate goal of providing the public with better options to manage their conditions. Typically there are three phases of clinical testing, each with a specific purpose in determining the safety of a treatment for use by the public. If the results are positive in the first two phases, the therapy will proceed to Phase III. The data gathering, analysis, and reporting that are necessary to complete these trials can take several years.
Participating in a Clinical Trial
Both those with Alzheimer’s disease and healthy individuals may consider participating in clinical trials. Each trial has its own protocol or set of guidelines, and volunteers must meet certain criteria to qualify for inclusion. Before making a decision, get as much information as possible about the trials and think seriously benefits and risks of volunteering. Those who participate are helping others with Alzheimer’s disease by taking these experimental treatments, and they may have access to medical care. However, there may be side effects, or the treatments may not be effective, and participation will require a time commitment.
- View or download Clinical Trials: Your Questions Answered (Publication)